Markets
News
Analysis
Tools
Learn
Stock
Score
Scan to Download
One power score. Smarter investment decisions
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Sign Up
Sign Up
Markets
/
Stocks
/
nasdaq-cai
/
Caris Life Sciences Inc
CAI
33.660
USD
+0.540
+1.63%
Close 09/16, 16:00(ET)
Quotes delayed by 15 min
0.000
USD
0.000
Pre-market 09/17, 09:30 (ET)
9.46B
Market Cap
Loss
P/E TTM
Caris Life Sciences Inc
33.660
+0.540
+1.63%
Overview
Company
Financials
Analysis
Statements
Income Statement
Balance Sheet
Cash Flow Statement
Overview
Company
Financials
Analysis
Statements
Income Statement
Balance Sheet
Cash Flow Statement
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q2
FY2025Q1
Total revenue
--
181.40M
--
120.92M
Revenue
--
--
--
120.92M
Cost of revenue
--
67.71M
--
63.85M
Operating expenses
--
199.39M
--
178.87M
R&D expenses
--
25.05M
--
23.07M
Depreciation, depletion, and amortization
--
6.41M
--
7.04M
Other operating expenses
--
--
--
1.00K
Operating profit
--
-17.99M
--
-57.95M
Net non-operating interest income (expenses)
Non-operating interest income
--
1.62M
--
503.00K
Non-operating interest expense
--
19.21M
--
12.78M
Special income (expenses)
--
-35.80M
--
-32.33M
Other non-operating income (expenses)
--
-411.00K
--
-17.00K
Income before tax
--
-71.79M
--
-102.58M
Income tax
--
0.00
--
0.00
Income after tax
--
-71.79M
--
-102.58M
Net income from continuous operations
--
-71.79M
--
-102.58M
Net income attributable to controlling interests
--
-517.20M
--
-127.04M
Preferred share dividend
--
384.44M
--
24.46M
Net income attributable to common shareholders
--
-517.20M
--
-127.04M
Basic earnings per share
--
-1.84
--
-0.46
Diluted earnings per share
--
-1.84
--
-0.46
Dividend per share
--
0.00
--
0.00
Currency unit
USD
USD
Audit opinions
--
--
KeyAI
Please log in to use KeyAI
Log in
Sign Up